Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Loading

Please wait while we load your information from QuoteMedia.

Company News

As of August 10, 2025 • 10:00 PM ET

Date/Time Source News Release
08/05/2025 06:30 AM EDT Business Wire Compass Pathways to Participate in Canaccord Genuity 45th Annual Growth Conference on August 12, 2025 in Boston, MA
07/31/2025 06:30 AM EDT Business Wire Compass Pathways Announces Second Quarter 2025 Financial Results and Business Highlights
07/29/2025 06:30 AM EDT Business Wire Compass Pathways Appoints Justin Gover to Board of Directors
07/22/2025 06:30 AM EDT Business Wire Compass Pathways to Announce Second Quarter Financial Results on July 31, 2025
07/10/2025 04:00 PM EDT Business Wire Compass Pathways to Participate in HC Wainwright @Home Series Interview on July 14th, 8:00am ET
07/01/2025 09:50 AM EDT GlobeNewswire Global Neuro-Psychiatric Disorders & Treatment Market Projected to Reach $166 Billion by 2032
06/23/2025 06:30 AM EDT Business Wire Compass Pathways Successfully Achieves Primary Endpoint in First Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
05/14/2025 06:30 AM EDT Business Wire Compass Pathways to Participate in 2025 RBC Capital Markets Global Healthcare Conference
05/08/2025 06:30 AM EDT Business Wire Compass Pathways Announces First Quarter 2025 Financial Results and Business Highlights
04/29/2025 06:30 AM EDT Business Wire Compass Pathways Establishes Strategic Collaboration with HealthPort to Inform the Potential Delivery of COMP360 Synthesized Psilocybin Treatment in Underserved Communities
Page

Additional News

As of August 10, 2025 • 10:00 PM ET

Date/Time Source News Release
08/03/2025 06:43 AM EDT SeekingAlpha Compass Pathways: Overly Confident Management Or Overly Skeptical Market
07/31/2025 12:34 PM EDT SeekingAlpha Psychedelic stocks up after report on AbbVie-Gilgamesh deal talks
07/31/2025 10:33 AM EDT SeekingAlpha Compass Pathways outlines FDA engagement and accelerated pathways for COMP360 in TRD while advancing PTSD program
07/31/2025 10:32 AM EDT SeekingAlpha COMPASS Pathways plc (CMPS) Q2 2025 Earnings Call Transcript
07/31/2025 07:00 AM EDT US Earnings Reports Expected US Company Earnings on Thursday, July 31st, 2025
07/31/2025 06:42 AM EDT SeekingAlpha COMPASS Pathways ADS GAAP EPS of -$0.41 beats by $0.02
07/31/2025 05:31 AM EDT US Earnings Reports Expected earnings - COMPASS Pathways Plc
07/30/2025 04:14 PM EDT Investing News Network Psychedelics Market Update: H1 2025 in Review
07/30/2025 11:00 AM EDT SeekingAlpha COMPASS Pathways ADS Q2 2025 Earnings Preview
07/20/2025 04:48 AM EDT Motley Fool These 2 Stocks Could More Than Double Your Money, According to Wall Street. Is It Time to Buy?
Page

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.